scholarly journals Inhibition of neuronal nitric oxide synthase by 6-nitrocatecholamines, putative reaction products of nitric oxide with catecholamines under oxidative stress conditions

2001 ◽  
Vol 356 (1) ◽  
pp. 105 ◽  
Author(s):  
Anna PALUMBO ◽  
Giuseppe ASTARITA ◽  
Marco d’ISCHIA
Nitric Oxide ◽  
2007 ◽  
Vol 16 (3) ◽  
pp. 331-338 ◽  
Author(s):  
Roberto M. Saraiva ◽  
Khalid M. Minhas ◽  
Meizi Zheng ◽  
Eleanor Pitz ◽  
Adriana Treuer ◽  
...  

2001 ◽  
Vol 356 (1) ◽  
pp. 105-110 ◽  
Author(s):  
Anna PALUMBO ◽  
Giuseppe ASTARITA ◽  
Marco d'ISCHIA

6-Nitrodopamine and 6-nitronoradrenaline (6-nitronorepinephrine), putative products of the nitric oxide (NO)-dependent nitration of dopamine and noradrenaline, are reported to be reversible, competitive inhibitors of neuronal nitric oxide synthase (nNOS) with Ki values of 45 and 52μM respectively. The nitrocatecholamines inhibited H2O2 production in the absence of l-arginine and tetrahydrobiopterin (BH4) (the IC50 values for 6-nitrodopamine and 6-nitronoradrenaline were 85 and 55μM respectively) but without affecting cytochrome c reduction. The apparent Ki values for nitrocatecholamine inhibition of enzyme activation by BH4 were 18μM for 6-nitrodopamine and 40μM for 6-nitronoradrenaline. Both nitrocatecholamines antagonized the dimerization of nNOS induced by BH4 and by l-arginine, the effect being reversed by BH4 (more than 10μM) and l-arginine (e.g. 100μM). Overall, these results suggest that nitrocatecholamines interfere with nNOS activity by binding to the enzyme in the proximity of the substrate and BH4-binding sites near the haem group.


2007 ◽  
Vol 101 (5) ◽  
pp. 1327-1337 ◽  
Author(s):  
Katia Aquilano ◽  
Giuseppe Filomeni ◽  
Sara Baldelli ◽  
Sara Piccirillo ◽  
Angelo De Martino ◽  
...  

Nitric Oxide ◽  
2006 ◽  
Vol 14 (4) ◽  
pp. 60 ◽  
Author(s):  
Roberto M. Saraiva ◽  
Meizi Zheng ◽  
Khalid M. Minhas ◽  
Eleanor Pitz ◽  
Karl H. Schuleri ◽  
...  

2008 ◽  
Vol 108 (2) ◽  
pp. 269-275 ◽  
Author(s):  
Katsutoshi Nakahata ◽  
Hiroyuki Kinoshita ◽  
Toshiharu Azma ◽  
Naoyuki Matsuda ◽  
Keiko Hama-Tomioka ◽  
...  

Background Vascular dysfunction induced by hyperglycemia has not been studied in cerebral parenchymal circulation. The current study was designed to examine whether high glucose impairs dilation of cerebral parenchymal arterioles via nitric oxide synthase, and whether propofol recovers this vasodilation by reducing superoxide levels in the brain. Methods Cerebral parenchymal arterioles in the rat brain slices were monitored using computer-assisted videomicroscopy. Vasodilation induced by acetylcholine (10 to 10 m) was obtained after the incubation of brain slices for 60 min with any addition of l-glucose (20 mm), d-glucose (20 mm), or propofol (3 x 10 or 10 m) in combination with d-glucose (20 mm). Superoxide production in the brain slice was determined by dihydroethidium (2 x 10 m) fluorescence. Results Addition of d-glucose, but not l-glucose, reduced arteriolar dilation by acetylcholine, whereas the dilation was abolished by the neuronal nitric oxide synthase inhibitor S-methyl-l-thiocitrulline (10 m). Both propofol and the superoxide dismutase mimetic Tempol (10 m) restored the arteriolar dilation in response to acetylcholine in the brain slice treated with d-glucose. Addition of d-glucose increased superoxide production in the brain slice, whereas propofol, Tempol, and the nicotinamide adenine dinucleotide phosphate (NAD[P]H) oxidase inhibitor apocynin (1 mm) similarly inhibited it. Conclusions Clinically relevant concentrations of propofol ameliorate neuronal nitric oxide synthase-dependent dilation impaired by high glucose in the cerebral parenchymal arterioles via the effect on superoxide levels. Propofol may be protective against cerebral microvascular malfunction resulting from oxidative stress by acute hyperglycemia.


Sign in / Sign up

Export Citation Format

Share Document